Related Experiment Videos
Analysis and detection of B cell neoplasms
Summary
Fluorescence-activated cell sorting (FACS) detects minimal B cell lymphoma cells in blood. This sensitive method reveals
Area of Science:
- Immunology
- Hematology
Background:
- B cell lymphomas are cancers of white blood cells that can be difficult to detect.
- Current diagnostic methods may not identify very small numbers of tumor cells.
Purpose of the Study:
- To describe the use of fluorescence-activated cell sorting (FACS) for sensitive detection of B cell lymphoma cells.
- To establish criteria for identifying tumor cells within normal cell populations using FACS.
Main Methods:
- Analysis of human B cell lymphoma cells using FACS.
- Quantification of surface kappa or lambda immunoglobulins (Ig) for tumor cell identification.
- Comparison of normal and tumor cell fluorescence patterns.
Main Results:
- Tumor cells identified by a 'clonal excess' of a single light chain type at specific fluorescence intensities.
- Detection of as few as 1% tumor cells in chronic lymphocytic leukemia and 0.1% in lymphoma.
- Circulating tumor cells identified in most B cell lymphoma patients with normal cytologic analysis.
Conclusions:
- FACS is a highly sensitive method for detecting B cell lymphoma cells.
- Subclinical leukemia is frequently present in B cell lymphomas.
- FACS can identify minimal residual disease and aid in diagnosis.